Urogenital Neoplasms
Showing 51 - 75 of 1,033
Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- Patient-specific adaptive therapy
- +2 more
-
Camperdown, New South Wales, Australia
- +6 more
Jan 11, 2023
Rectal Cancer, Advanced Cancer Trial in Guangzhou (Complete Preservation of Denonvilliers' Fascia)
Recruiting
- Rectal Cancer
- Advanced Cancer
- Complete Preservation of Denonvilliers' Fascia
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital, Sun Yat-sen University
Apr 27, 2021
Prostate Cancer, Prostatic Tumor, Urogenital Tumors Trial in Modena ([68Ga]Ga-PSMA-11 PET/CT)
Recruiting
- Prostate Cancer
- +5 more
- [68Ga]Ga-PSMA-11 PET/CT
-
Modena, ItalyAzienda Ospedaliero-Universitaria di Modena
Sep 16, 2020
Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)
Unknown status
- Ovarian Neoplasms
- +23 more
-
Nanjing, Jiangsu, ChinaJiangSu Cancer Hospital
Nov 8, 2020
Female Urogenital Diseases, Breast Cancer Female Trial (C02 microablative laser, Regenerative topical treatment)
Not yet recruiting
- Female Urogenital Diseases
- Breast Cancer Female
- C02 microablative laser
- Regenerative topical treatment
- (no location specified)
Nov 28, 2022
Ovarian Tumors, Carcinoma, Ovarian Epithelial, Tumor of Stomach Trial (Pembrolizumab, Lenvatinib)
Not yet recruiting
- Ovarian Neoplasms
- +7 more
- (no location specified)
Aug 17, 2020
Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)
Recruiting
- Metastatic Hormone Naive Prostate Cancer
-
Sydney, New South Wales, Australia
- +4 more
Nov 4, 2022
Description of Population With Genitourinary Tumors and COVID-19
Active, not recruiting
- Covid19
- Genito Urinary Cancer
-
Hospitalet de Llobregat, Barcelona, Spain
- +31 more
Sep 21, 2021
Melanoma, Colon Cancer, Gastrointestinal Cancer Trial run by the NCI (National Cancer Institute (NCI)-4650, a messenger
Terminated
- Melanoma
- +4 more
- National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 22, 2020
Advanced or Metastatic Solid Tumors Trial in Worldwide (MK-3475A, Pembrolizumab, Pemetrexed)
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- MK-3475A
- +7 more
-
Santiago, Region M. De Santiago, Chile
- +14 more
Aug 10, 2022
Prostate Cancer Trial in Australia, New Zealand (Adjuvant Radiotherapy, Early Salvage Radiotherapy)
Active, not recruiting
- Prostate Cancer
- Adjuvant Radiotherapy
- Early Salvage Radiotherapy
-
Campbelltown, New South Wales, Australia
- +35 more
Nov 16, 2022
Superficial Bladder Cancer Trial in Worldwide
Completed
- Superficial Bladder Cancer
-
Kansas City, Kansas
- +18 more
Oct 11, 2021
Genitourinary Cancer, Kidney Cancer Trial in United States (Sunitinib, Questionnaire)
Completed
- Genitourinary Cancer
- Kidney Cancer
- Sunitinib
- Questionnaire
-
Stanford, California
- +4 more
Feb 14, 2020
Schistosoma Related Bladder Diseases.
Not yet recruiting
- Schistosoma Haematobium
- Immunohistochemistry staining,
- microscopic examination of urine
-
Assiut, EgyptAssiut University Hospital
Jul 4, 2023
Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal
Not yet recruiting
- Urothelial Carcinoma
- +7 more
- Jelmyto (mitomycin) for pyelocalyceal solution
- (no location specified)
May 22, 2023
Germ Cell Tumor Trial in Australia, New Zealand, United States (Bleomycin (active name: Bleomycin Sulfate), Etoposide,
Recruiting
- Germ Cell Tumor
- Bleomycin (active name: Bleomycin Sulfate)
- +4 more
-
New York, New York
- +27 more
Nov 25, 2021
Prostate Cancer Metastatic Trial in United States (ARV-766)
Recruiting
- Prostate Cancer Metastatic
- ARV-766 Part A
- ARV-766 Part B
-
Duarte, California
- +20 more
Jan 31, 2023
Breast Cancer, Gastrointestinal Cancer, Genitourinary Cancer Trial in Richmond (Doxorubicin, Sildenafil)
Completed
- Breast Cancer
- +4 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Aug 22, 2019
Breast Cancer, Brain Cancer, Gastrointestinal Cancers Trial in Chicago (IGF-Methotrexate conjugate)
Completed
- Breast Cancer
- +7 more
- IGF-Methotrexate conjugate
-
Chicago, IllinoisUniversity of Illinois at Chicago
Aug 20, 2019
Prostate Cancer, Kidney Cancer, Genitourinary Cancer Trial in Boston (Postwire)
Completed
- Prostate Cancer
- +2 more
- Postwire
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 6, 2019
Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
Completed
- Gastric Cancer
-
Seoul, Korea, Republic ofSamsung Medical center
May 17, 2019
Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2
Unknown status
- Metastatic Gastrointestinal Cancer
- Genitourinary Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
May 17, 2019
Rectal Tumors Trial in Larissa (Pelvic Intraoperative Neuromonitoring)
Recruiting
- Rectal Neoplasms
- Pelvic Intraoperative Neuromonitoring
-
Larissa, GreeceUniversity Hospital of Larissa
Sep 19, 2021